Skip to main content
SpringerLink
Log in

Platelet-rich plasma for hip osteoarthritis: comparing the variables in production protocol and composition

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Data sharing is not applicable to this article as no new data were created or analysed in this study.

References

  1. Medina-Porqueres I, Ortega-Castillo M, Muriel-Garcia A (2020) Effectiveness of platelet-rich plasma in the management of hip osteoarthritis: a systematic review and meta-analysis. Clin Rheumatol. https://doi.org/10.1007/s10067-020-05241-x

  2. Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R, Giannini S (2013) Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 36(12):e1501–e1508. https://doi.org/10.3928/01477447-20131120-13

    Article  Google Scholar 

  3. Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, Tschon M, Giavaresi G (2016) Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med 44(3):664–671. https://doi.org/10.1177/0363546515620383

    Article  Google Scholar 

  4. Di Sante L, Villani C, Santilli V, Valeo M, Bologna E, Imparato L, Paoloni M, Iagnocco A (2016) Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason 18(4):463–468. https://doi.org/10.11152/mu-874

    Article  PubMed  Google Scholar 

  5. Doria C, Mosele GR, Caggiari G, Puddu L, Ciurlia E (2017) Treatment of early hip osteoarthritis: ultrasound-guided platelet rich plasma versus hyaluronic acid injections in a randomized clinical trial. Joints 5(3):152–155. https://doi.org/10.1055/s-0037-1605584

    Article  PubMed  PubMed Central  Google Scholar 

  6. Le ADK, Enweze L, DeBaun MR, Dragoo JL (2018) Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med 11(4):624–634. https://doi.org/10.1007/s12178-018-9527-7

    Article  PubMed  PubMed Central  Google Scholar 

  7. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37(11):2259–2272. https://doi.org/10.1177/0363546509349921

    Article  PubMed  Google Scholar 

  8. Kon E, Di Matteo B, Delgado D, Cole BJ, Dorotei A, Dragoo JL, Filardo G, Fortier LA, Giuffrida A, Jo CH, Magalon J, Malanga GA, Mishra A, Nakamura N, Rodeo SA, Samspon S, Sánchez M (2020) Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system. Expert Opin Biol Ther. https://doi.org/10.1080/14712598.2020.1798925 Advance online publication

Download references

Author information

Authors and Affiliations

  1. Division of Surgery, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India

    Khan Sharun & Abhijit M. Pawde

Authors
  1. Khan Sharun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhijit M. Pawde
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khan Sharun.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharun, K., Pawde, A.M. Platelet-rich plasma for hip osteoarthritis: comparing the variables in production protocol and composition. Clin Rheumatol 39, 3899–3901 (2020). https://doi.org/10.1007/s10067-020-05337-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05337-4

Search

Navigation